Register now

11111

Speakers

11111

guests

Speakers

Dr. Alejandro Videla

Head of the Pulmonology Service, Hospital Universitario Austral, Argentina

Dr. Alfredo Guerreros

Corporate Medical Director of the International Clinic, Peru

Dr. Carlos Álvarez

Director of UNICEF, Peru

Dr. Carlos del Río

IDSA The Infectious Diseases Society of America President

Dr. Catia Cilloniz

Associate Professor, University of Barcelona, Spain

Dr. Charles Dela Cruz

Associate Professor of Medicine, Yale School of Medicine, USA

Dr. Cesar Munayco Escate

General Director of the National Center for Epidemiology, Prevention and Disease Control, Peru

Dr. Chris Murray

Director of the Institute for Health Metrics and Evaluation (IHME), USA

Dr. Claudio Lanata

Researcher, Nutritional Research Institute, Peru

Dr. Gail Rodgers

Deputy Director, Pneumonia, Bill and Melinda Gates Foundation

Dr. Gisela Robles

Global Burden of Disease Reseacher, The Centre for Tropical Medicine and Global Health, UK

Dr. Jarbas Barbosa

Director of the Pan American Health Organization

Dr. Juana del Valle

Teacher Researcher, Universidad Peruana de Ciencias Aplicadas-UPC, Peru

Eng. Lucio Flavio de Magalhaes Brito

Lancet Global Health Oxygen Commissioner, Brazil

Dr. Murat Ozturk

Senior Advisor, Revolving Fund for Access to Vaccines, PAHO, USA

Dr. Patricia J. García

Member, Institute of Medicine of the National Academies, Peru

Dr. Patricia Rivera

President of the American Thoracic Society (ATS)

Dr. Pilar Collantes

President Voces Ciudadanas, Peru

Dr. Roberto Accinelli

Director of Height Research Institute, Peru

Dr. Romina Libster

Vaccine Trials Network Director, Vaccines and respiratory viruses research, USA

Dr. Walter Curioso

Vice-Rector for Research, Continental University, Peru

Dr. William Checkley

Associate Professor, Johns Hopkins Bloomberg School of Public Health, USA

Dr. Yasir Bin Nisar

Medical Officer, WHO

Carina King, MD

Karolinska Institute, Department for Global Public Health, Solna, Sweden

Dimitris Kontopidis, MD

President, European Lung Foundation (ELF)

Fiona Russell, PROF

Department of Paediatrics, The University of Melbourne, Melbourne, VIC 3052, Australia; Infection and Immunity, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Francisco Arancibia, PROF

Past- President, The Latin American Thoracic Association (ALAT)

Heather Zar, PROF

Department of Pediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa.

Julio Tejada, MD

President of the College of Physicians and Surgeons of Guatemala

Karen Czischke, MD

Department of Pulmonary Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile

Kevin Baker, MD

International Consultan

Kjeld Hansen, MR

Representative of The European Lung Foundation

Noni Macdonald, PROF

Division of Infectious Diseases, Department of Paediatrics, Dalhousie University and IWK Health Centre, Halifax, NS

Refiloe Masekela, PROF

President, Pan African Thoracic Society (PATS)

Zoë Mullan, MD

Editor-in-Chief, The Lancet Global Health

Jarbas Barbosa, MD

Director Pan American Health Organization (PAHO)

Keith Klugman, PROF

Director of Pneumonia and Pandemic Preparedness, Gates Foundation

Add Your Heading Text Here

Add Your Heading Text Here

Add Your Heading Text Here

Add Your Heading Text Here

Dear Colleagues & Friends,

As Chairpersons of the 4th Global Conference for World Pneumonia Day 2024, it gives us great pleasure to invite you to join our event, which is part of the Worldwide Pneumonia Awareness Campaign-Pneumolight, with the support of the Philippine College of Physicians (PCP) in Manila, to be held on 9 November 2024.

Despite the global impact of the COVID-19 pandemic, pneumonia remains a neglected disease. Sadly, the 2021 Global Burden of Disease report showed that 2.1 million people died of pneumonia in that year; children under five years and adults over 70 continued to be the most vulnerable populations, with more than 500,000 and 1 million pneumonia-related deaths respectively. Another important problem is the impact of antimicrobial resistance (AMR); according to the 2019 GBD report, 1.27 million deaths were attributable to bacterial AMR in that year, and one in five deaths caused by AMR occurred in children under five years old. The 2019 GBD report identified Streptococcus pneumoniae as the most frequent pathogen causing pneumonia,
contributing to 16% of the deaths attributable to AMR.

Although great progress continues to be made, the worldwide burden of pneumonia remains huge. We need everyone to know about the disease and its impact on our health, and above all, we need to show that it can be prevented. Pneumonia must be recognized as a major global health problem. Until this recognition comes, we will continue our attempts to educate and prevent, because we know that education is prevention and prevention saves lives.

Working together, we can move the world because we know that if we fight, we can win!!!!

Yours sincerely,

Catia Cilloniz
Guinevere Dy-Agra
Rodolfo S. Pagcatipunan Jr

This will close in 0 seconds

This will close in 0 seconds

This will close in 0 seconds

Louis Bont, MD, PhD

Louis Bont, MD, PhD, is a Pediatric Infectiologist-Immunologist and the head of the Pediatric Department at the University Medical Center Utrecht, The Netherlands. He is the founding chairman of ReSViNET, an international respiratory syncytial virus (RSV) research consortium. His specific research interests include RSV pathogenesis and the burden of disease.

Dr. Bont's work focuses on unraveling the role of neutrophils, RSV-related mortality, and long-term airway disease following RSV infection. He is the lead investigator of the INFORM study, a large prospective global clinical virology study that aims to uncover the molecular epidemiology of RSV in over 2000 children. He also leads the RSV GOLD mortality registry, funded by the Bill and Melinda Gates Foundation.

His group collaborates with the World Health Organization on RSV surveillance and vaccine development. Dr. Bont’s research emphasizes clinical and translational mechanisms of disease and the identification of intervention targets for RSV bronchiolitis. He has been the lead author of over 300 publications in peer-reviewed medical journals.

Additionally, he founded the Training of Upcoming Leaders in Pediatric Science (TULIPS), a career training network for clinician scientists in the field of Child Health.

This will close in 0 seconds

This will close in 0 seconds